Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Mizuho raised the price target for Microsoft Corporation (NASDAQ:MSFT) from $450 to $480. Mizuho analyst Gregg Moskowitz maintained an Outperform rating. Microsoft shares gained 0.1% to close at $453.96 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. boosted the price target for Revolution Medicines, Inc. (NASDAQ:RVMD) from $44 to $56. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Revolution Medicines shares gained 1.9% to close at $46.00 on Monday. See how other analysts view this stock.
- Morgan Stanley increased the price target for The Goldman Sachs Group, Inc. (NYSE:GS) from $475 to $513. Morgan Stanley analyst Betsy Graseck maintained an Overweight rating. Goldman Sachs shares gained 2.6% to close at $492.23 on Monday. See how other analysts view this stock.
- Keefe, Bruyette & Woods increased ...